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Dr. Amin Fazeli
 
 (Dermatology): A 68-year-old man was evaluated in this hospital by a
dermatologist because of progressive thickening of the skin of the arms and legs.
The patient had had type 2 diabetes mellitus for 35 years, complicated by end-stage
renal disease that required hemodialysis, diabetic neuropathy that resulted in leg pain
and difficulty walking, chronic foot ulcers, and retinopathy; he was legally blind. He
had coronary artery disease that had necessitated bypass grafting of four vessels, par-
oxysmal atrial fibrillation, and hypertension.
For the seven months before the evaluation, progressive thickening of the skin, par-
ticularly of the legs, had developed. He had also had weakness of the legs and had fall-
en at home with increasing frequency. Electromyographic studies, six months before
admission, showed a severe generalized axonal sensorimotor polyneuropathy. Four
months before he was admitted, examination of a skin-biopsy specimen from the leg
disclosed subcutaneous fibrosis, involving both lobules and septa, with extension into
the deep dermis. These symptoms were believed to be most consistent with lipoderma-
tosclerosis, but the differential diagnosis had included nephrogenic fibrosing der-
mopathy. One month before admission, he visited the emergency room of another
hospital, and reported frequent falls at home and weakness that had caused him to
start using a walker.
Four days before the evaluation by the dermatologist, he had been admitted to this
hospital because of upper gastrointestinal bleeding. For the preceding 6 to 12 months,
he had had intermittent indigestion and heartburn, which were relieved by antacids.
He did not have chest pain, abdominal pain, or diarrhea.
The patient was a retired firefighter. He had been living in a rehabilitation facility for
the past three weeks because of his inability to walk. His medications included aspirin,
insulin, docusate sodium, heparin (500 units subcutaneously, twice daily), gabapentin
(100 mg, three times per week), vitamin B complex, atorvastatin, atenolol, nifedipine,
isosorbide mononitrite, warfarin, and prednisolone eye drops.
The blood urea nitrogen level was 33 mg per deciliter (11.78 mmol per liter), the
creatinine level 4.8 mg per deciliter (424.32 µmol per liter), the albumin level 2.6 g per
presentation of case
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liter, the globulin level 4.4 g per deciliter, the glu-
cose level 136 mg per deciliter (7.55 mmol per li-
ter), and the glycosylated hemoglobin value 8.3
percent. The complete blood count, electrolyte lev-
els, and results of liver-function tests were normal.
A chest radiograph showed no pulmonary edema.
Fluids were administered intravenously, and eso-
meprazole was given orally. Esophagogastroduo-
denoscopy later that day revealed esophagitis with
linear ulceration and erosive gastritis, without signs
of current or recent bleeding from either site. Oral
esomeprazole was given twice daily. The epigastric
pain and bleeding did not recur.
A dermatologist examined the patient’s skin on
the fourth hospital day; among the findings were
waxy, taut, hardened plaques with brown pigmen-
tation extending from both upper thighs to the most
distal point on the toes, with increasing tautness
distally and from the upper arms to the fingers.
These findings were most prominent over the flex-
ures of the wrists and elbows and the area between
the thenar and hypothenar prominences. There
were 30-to-40-degree flexion contractures of both
elbows and both knees.
A diagnostic procedure was performed.
 
Dr. Samuel L. Moschella:
 
 May we see the clinical pho-
tographs?
 
Dr. Bonnie T. Mackool:
 
 The skin had a brawny ap-
pearance, and the arms and legs were hyperpig-
mented. Large areas of the skin appeared shiny, with
prominent induration extending from the upper
arms to the distal fingers (Fig. 1A). The induration
was most prominent on the upper arms, with areas
of normal skin between smooth hardened plaques
and a very gradual transition from the indurated
plaques to normal skin. Flexion contractures of the
fingers and the elbows were present (Fig. 1B).
There were contractures of the knees; the patient
was unable to extend his legs completely (Fig. 1C).
The induration was particularly prominent in the
toes and feet and extended upward to the thighs,
with continuous mild erythema in the lower legs
and nonpitting, shiny induration on the feet (Fig.
1D). There was no hair on the legs, and the skin
had a dry appearance; the distal pulses were absent.
Bandages covered bilateral and symmetric oval-
shaped ulcers on the heels.
 
Dr. Moschella
 
: This 68-year-old man with type 2
diabetes mellitus complicated by end-stage renal
disease had waxy and erythematous plaques involv-
ing both arms and legs; the most prominent involve-
ment was in areas of flexure, with resulting con-
tractures. Skin manifestations are associated with
both end-stage renal disease and diabetes mellitus,
which should be considered in the differential di-
agnosis (Tables 1 and 2).
 
1
 
The violaceous reticulated dermatitis associated
with plaques of calcific uremic arteriopathy usually
appears on the extremities and tends to form ex-
tremely painful ischemic ulcers, which when biop-
sied reveal calcification of vessel walls and intrale-
sional deposition of fibrin.
 
2
 
 Porphyria cutanea tarda
may produce fragility of the skin, with the forma-
tion of blisters and milia on exposed areas and scle-
rotic patches that are clinically and histologically
consistent with morphea, hypertrichosis of the face,
and periorbital erythema.
 
1
 
 None of these changes
were seen in this patient.
Scleredema diabeticorum is characterized by
thickened skin that appears waxy and by limited
joint mobility and sclerodactyly (Table 2).
 
2
 
 Dramatic
induration of the skin of the neck and upper back,
and less severe induration of the chest, face, and
extremities, which may affect joint mobility, are due
to glycosaminoglycan deposition. Systemic involve-
ment, such as that seen with serositis, can occur.
This condition can be ruled out in this case because
of the distribution of the cutaneous eruption, the
lack of systemic involvement, and the histopatho-
logical features of the biopsy specimen. The signs of
necrobiosis lipoidica diabeticorum
 
2
 
 are  well-cir-
cumscribed, waxy, yellow-to-brown, initially indu-
rated and later atrophic plaques on the legs, with
raised red telangiectatic borders, and the presence
of characteristic palisading granulomas on histo-
pathological examination.
 
lipodermatosclerosis
 
An initial biopsy specimen of the skin of this pa-
tient’s leg was interpreted histopathologically as
consistent with lipodermatosclerosis
 
3
 
; however, the
differential diagnosis includes nephrogenic fibros-
ing dermopathy. Lipodermatosclerosis usually af-
fects women who have venous insufficiency and
stasis. It is characterized by well-circumscribed, in-
durated, inflamed, hyperpigmented plaques of the
lower part of the legs with the subsequent physical
appearance of an inverted champagne bottle. Lipo-
dermatosclerosis is characterized by the histolog-
ic changes seen in stasis dermatitis, ischemic fat
necrosis, and later progressive septal fibrosis and
differential diagnosis
The New England Journal of Medicine 
Downloaded from nejm.org at UMASS WORCESTER on April 26, 2015. For personal use only. No other uses without permission. 
 Copyright © 2004 Massachusetts Medical Society. All rights reserved. 
 n engl j med 
 
351;21
 
www.nejm.org november 
 
18, 2004
 
case records of the massachusetts general hospital
 
2221
 
obliteration of the fat lobules. The clinical and his-
topathological features of this case are not those of
lipodermatosclerosis.
 
nephrogenic fibrosing dermopathy
 
Cowper et al.
 
4
 
 described 14 patients with renal fail-
ure in whom a cutaneous disease similar to scler-
omyxedema developed; most had undergone hemo-
dialysis, but some had not. The distribution and
nature of the lesions, the absence of a paraproteine-
mia and visceral involvement, the presence of scle-
rodactyly and contractures, and the fibroblastic his-
topathological picture led the investigators
 
5
 
 to call
this new entity nephrogenic fibrosing dermopathy.
Recently, Ting et al.
 
6
 
 reported a case with systemic
involvement. Forty-nine cases have been reported to
the Centers for Disease Control and Prevention. The
disorder has occurred in patients receiving perito-
neal dialysis and in a few patients who have renal in-
sufficiency but who have never undergone dialysis.
 
7
 
Nephrogenic fibrosing dermopathy is character-
ized by diffuse, cutaneous, hyperpigmented, brawny
 
Figure 1. Photographs of the Skin.
 
There is thickening of the skin of the arm (Panel A), most prominent over the flexures of the wrists and elbows and the 
area between the thenar and hypothenar prominences. There are flexion contractures of the fingers and a waxy appear-
ance to the skin (Panel B). On the legs (Panel C), there are waxy, taut, hardened plaques with brown pigmentation ex-
tending from both upper thighs to the most distal point on the toes, with a shiny appearance to the skin of the feet 
(Panel D). There are flexion contractures of the knees, and bandages cover symmetrical ulcers on the heels.
A B
C D
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induration, erythematous or skin-colored plaques
with irregular borders with ameboid projections,
firm discrete papules, and subcutaneous nodules;
there are islands of sparing in the individual
plaques.
 
8,9
 
 The eruptions usually start on the ex-
tremities, especially the lower legs, extend to the
trunk, and rarely involve the face. Yellowish palmar
papules and yellow nodules of sclera have been
seen. Pruritus, burning sensations, and pain in the
skin lesions have been described.
The cause of nephrogenic fibrosing dermopathy
is unknown. No infectious agents, drugs, or envi-
ronmental toxins have been implicated as possible
agents, despite comprehensive studies.
 
6
 
 Investiga-
tion of the materials used in hemodialysis, perito-
neal dialysis, and transplantation have provided no
clues.
 
10
 
 The roles of high-flux dialysis and marked
volume overloading are being investigated.
 
10
 
This patient’s clinical history and skin lesions
are typical of nephrogenic fibrosing dermopathy.
 
11
 
However, the differential diagnosis includes other
conditions that are characterized by dermal and
subcutaneous fibroplasias with or without sclero-
dactyly, and mucin deposition, or the presence of
dermal, subcutaneous, and musculoskeletal amy-
loid deposits (Table 3).
 
differential diagnosis of nephrogenic 
fibrosing dermopathy
 
Scleromyxedema
 
12,13
 
 is a chronic idiopathic disor-
der that produces indurated plaques, nodules, and
papules that contain dermal mucin and a variable
degree of fibrosis. These patients do not have thy-
roid disease. Leonine facies and paronychial or
auricular papular components may be present. Pa-
tients with scleromyxedema may also have systemic
symptoms, especially of the central nervous system
or cardiac system, such as paraproteinemia, elevat-
ed levels of muscle enzymes, and, rarely, myelodys-
plasia. The absence of lesions on the face, neck,
and hands; the marked visceral involvement or para-
proteinemia; and the histopathological features in
this case argue against this diagnosis.
Other disorders to be considered are morphea
(localized scleroderma),
 
14
 
 systemic sclerosis (scler-
oderma),
 
15
 
 eosinophilic fasciitis,
 
16
 
 and the eosin-
ophilia–myalgia syndrome.
 
17
 
 Morphea is character-
ized by ivory-colored, localized linear or generalized
plaques with violaceous borders; when these
plaques are examined histologically, homogenized
bundles of collagen are evident, with the absence
of mucin. When these lesions affect the extremi-
ties, especially in a linear fashion, they may mimic
nephrogenic fibrosing dermopathy. However unlike
those of nephrogenic fibrosing dermopathy, these
lesions have an erythematous border; they are
white, not waxy, in appearance, and they have a
characteristic histopathological picture of homog-
enized collagen with the absence of mucin. 
Systemic sclerosis, because of the thick, tight
skin, acrosclerotic changes, and associated pigmen-
tation, can appear similar to nephrogenic fibrosing
dermopathy. However, on closer inspection, there is
involvement of the face (pinched facies) and telan-
giectatic mats, which can also appear on the hands
and face. The patients with this disorder may also
have the changes in the distal digital pulp associat-
ed with Raynaud’s phenomenon. Visceral involve-
ment, especially of the gastrointestinal tract, lung,
and kidneys, may occur. Such patients will have
autoantibodies. No systemic changes or autoanti-
bodies were present in this case.
Patients with eosinophilic fasciitis can have a
woody induration of the distal extremities and con-
 
Table 1. Cutaneous Manifestations of End-Stage
Renal Disease.
 
Pruritus
Perforating disorders of skin (perforating folliculitis, per-
forating collagenosis, and Kyrle’s disease)
Metastatic calcification
Benign nodular calcification
Calcific uremic arteriopathy
Bullous dermatosis
Porphyria cutanea tarda
Pseudoporphyria
Nephrogenic fibrosing dermopathy
 
Table 2. Cutaneous and Connective-Tissue Changes
Associated with Diabetes Mellitus.
 
Dupuytren’s contracture
Diabetic cheiroarthropathy
Carpal tunnel syndrome
Scleredema diabeticorum
Necrobiosis lipoidica diabeticorum
Acquired perforating disorders
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tractures, with a loss of mobility. However, they
will have an elevated erythrocyte sedimentation rate,
hypergammaglobulinemia, a peripheral-blood eo-
sinophilia, and a deep-skin biopsy specimen will
show thickening of the deep fascia and the pres-
ence of a patchy infiltrate of lymphocytes, plasma
cells, and especially eosinophils. In a documented
incident,
 
18
 
 a separate disease called the eosino-
philia–myalgia syndrome developed in patients who
ingested a contaminated tryptophan; this syndrome
is characterized initially by fever and a generalized
morbilliform eruption and later by a scleroder-
moid eruption primarily confined to the extremi-
ties; a peripheral myopathy and neuropathy; and eo-
sinophilia and elevated levels of muscle enzymes.
Other than the sclerodermoid changes, none of the
above features were present in this patient.
 
diagnostic procedure
 
To confirm the diagnosis in patients with nephro-
genic fibrosing dermopathy, the biopsy should be
performed on a firm nodular or plaque lesion on
the lower leg, preferably the anterior thigh if it is
involved, because in such a location it would be
easier to take a deeper biopsy specimen, to close
the biopsy site, and to minimize the danger of de-
hiscence.
 
Dr. Nancy Lee Harris
 
 (Pathology): Dr. Kay, would
you please review the differential diagnosis in this
case, from your perspective as the rheumatology
consultant? 
 
Dr. Jonathan Kay:
 
 Two features of this patient’s
condition prompted rheumatologic consultation:
the scleroderma-like thickening of his skin and the
disabling flexion contractures of his fingers, el-
 
Table 3. Clinical and Histologic Features of Nephrogenic Fibrosing Dermopathy as Compared with Disorders That Appear Similar.
Disorder Distribution of Lesions
Clinical Morphologic
Features of Lesions
Histopathological
Features of Lesions Associated Conditions
 
Nephrogenic 
fibrosing 
dermopathy
Legs, feet, toes, arms, 
hands, fingers
Indurated plaques with 
pigmentation; sclero-
dactyly
Dermal spindle-cell proliferation 
(CD34+) with variable mucin de-
position and little inflammation; 
occasional multinucleated giant 
cells, elongated elastic fibers, and 
dystrophic calcification
Renal failure
Scleromyxedema Face, neck, ears, fingers Plaques, nodules, papules Dermal fibrosis, increased mucin 
(often in “pools”), lymphoplasma-
cellular infiltrate
Central nervous system, 
cardiac involvement; 
paraproteinemia
Morphea Ivory-colored, localized, 
linear plaques, 
erythematous border
Homogenized collagen; mucin not 
increased
Systemic sclero-
sis (sclero-
derma)
Face, neck, arms, legs, feet, 
hands
Thick, tight skin, pigmen-
tation, telangiectases; 
sclerodactyly with loss 
of digital pulp
Homogenized, thickened collagen; 
mucin not increased; variable 
inflammatory infiltrate
Gastrointestinal, renal, 
lung disease; 
Raynaud’s phenome-
non; serology
Eosinophilic 
fasciitis
Arms, legs, feet, hands Woody induration, con-
tractures
Fibrosis, lymphocytes, plasma cells, 
eosinophils
Elevated erythrocyte sedi-
mentation rate, hyper-
gammaglobulinemia, 
eosinophilia
Eosinophilia–
myalgia 
syndrome
Generalized (morbilliform 
rash); arms, legs, feet, 
hands (scleroderma-
like)
Morbilliform rash;
scleroderma-like foci
Mixed inflammatory infiltrate with 
eosinophils
Ingestion of tryptophan, 
myopathy, neuropa-
thy, eosinophilia, ele-
vated levels of muscle 
enzymes
Fibroblastic 
rheumatism
Fingers, elbows, knees Flesh-colored or erythema-
tous nodules
Myofibroblastic proliferation, often 
with some degree of inflammation
Fever, polyarthritis, Ray-
naud’s phenomenon
Beta
 
2
 
-micro-
globulin 
amyloidosis
Shoulders, carpal tunnels, 
flexor tendons of hands; 
tongue (macroglossia)
Periarticular thickening 
(shoulder pad); cuta-
neous papules (rare), 
nodules
Amyloid deposition Chronic renal failure
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bows, and knees. I will address the differential di-
agnosis of his joint contractures.
Joint contracture is defined as the limitation of
passive range of joint motion by structural changes
of soft tissues. Skin tightening, ligament or tendon
shortening, and imbalanced muscle contraction can
each produce joint contractures. These changes may
result from congenital abnormalities, trauma, pro-
longed immobilization, nerve injury, or other disor-
ders involving skin, muscle, tendons, or ligaments.
The clinical history is sufficient to rule out con-
genital syndromes, trauma, or prolonged immobi-
lization as the cause in this case. The primary symp-
tom of peripheral neuropathy in this patient was a
sensory loss without a motor component, which
consequently appears to be unlikely to contribute
to his flexion contractures. Physical examination
showed no imbalanced muscle contractions. Fibro-
blastic rheumatism is an uncommon syndrome
characterized by sclerodactyly, multiple cutaneous
nodules, and an inflammatory polyarthritis, the
joint distribution of which is similar to that of rheu-
matoid arthritis except for the additional promi-
nent involvement of the distal interphalangeal
joints of the hands. Patients may have flexion con-
tractures of the fingers.
 
19
 
 This patient had no his-
tory of inflammatory polyarthritis.
Patients with diffuse systemic sclerosis (scler-
oderma) may have flexion contractures, most often
involving the fingers and elbows
 
20
 
 but also occa-
sionally the knees.
 
21
 
 Cutaneous thickening ac-
counts for much of the limited joint motion ob-
served in patients with scleroderma. However,
flexion contractures of the fingers also may result
from musculotendinous shortening caused by fi-
brosis of the flexor digitorum superficialis and pro-
fundus muscles of the forearm.
 
22
 
 This patient had
no clinical features to suggest systemic sclerosis.
In patients with chronic renal failure who have
received long-term hemodialysis, shoulder periar-
thritis, carpal tunnel syndrome, and flexion contrac-
tures of the fingers may also develop as manifesta-
tions of beta
 
2
 
-microglobulin amyloidosis.
 
23
 
 The
flexion contractures of the fingers are caused by
amyloid infiltration of the flexor tendons, causing
the tendons to adhere to one another and produc-
ing functional shortening. However, beta
 
2
 
-micro-
globulin amyloidosis is not associated with sclero-
sis of the overlying skin. This patient reported no
shoulder pain and did not have either soft-tissue
fullness about his wrists or carpal tunnel syndrome.
Diabetic cheiroarthropathy develops in some
people with diabetes mellitus and is associated
with thickening of the skin over the fingers and
dorsum of the hands and limited joint mobility.
 
24
 
The digital sclerosis is often associated with flex-
ion contractures of the interphalangeal and meta-
carpophalangeal joints of the hands.
 
25
 
 Flexion
contractures of larger joints, such as the elbows,
shoulders, and knees, may also develop
 
.
 
 The prev-
alence of adhesive shoulder capsulitis, palmar flex-
or tenosynovitis of the hands, and Dupuytren’s dis-
ease is substanially greater in diabetic patients than
in others.
 
26
 
 Although these conditions are more
common in people with type 1 diabetes than in
those with type 2 diabetes, this difference is related
to the increased prevalence of these syndromes with
longer duration of diabetes. Patients with diabetes
who have shoulder and hand disorders are more
likely to have retinopathy, nephropathy, or neurop-
athy than are patients with diabetes who do not
have these disorders.
I believe that this patient’s joint contractures
were attributable to nephrogenic fibrosing der-
mopathy, caused by the thickened skin overlying
his fingers, elbows, and knees. Diabetic cheiroar-
thropathy might have been a contributing factor.
There did not appear to be sufficient abnormality
of the joints themselves to explain his limited joint
mobility.
 
Dr. Harris: 
 
Dr. Mackool, as the dermatologist
who evaluated this patient, would you give us your
clinical impressions?
 
Dr. Mackool:
 
 Nephrogenic fibrosing dermopathy
was the working diagnosis. The skipped areas of
induration with smooth transition to indurated
plaques and hyperpigmentation all supported this
diagnosis. I considered systemic sclerosis because
of the severe woody induration on the feet, but other
cutaneous and systemic manifestations of sclero-
derma were absent. I considered calciphylaxis, but
the plaques were not painful, and over the eight
months of progressive disease, purpura and ulcer-
ation, which are features of advanced calciphylaxis,
did not develop. I also considered scleredema dia-
beticorum, but the shininess of the skin and the
lack of involvement of the back, shoulders, and neck
rendered this diagnosis unlikely.
Skin-punch biopsies of affected areas of the
right lower leg and left anterior thigh were per-
formed.
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Nephrogenic fibrosing dermopathy.
Nephrogenic fibrosing dermopathy.
 
Dr. Vincent Liu:
 
 The specimens from the punch bi-
opsies of skin from the two sites showed similar
changes. On low-magnification scanning of the
specimen taken from the left anterior thigh, there
is mild hypercellularity of the dermis (Fig. 2A).
Higher magnification shows a spindle-cell prolif-
eration intercalated among the compact, clefted der-
mal collagen bundles that extends down through
the subcutaneous fat (Fig. 2B). Mucin deposition is
shown on the colloidal iron stain as blue staining
in the superficial dermis (Fig. 2C). On van Gieson’s
staining, elongated elastic fibers are highlighted in
the superficial dermis (Fig. 2D). Immunohisto-
chemical staining with antibodies to CD34 revealed
staining of the fibroblast-like cells (Fig. 2E). In sum-
mary, the skin-biopsy specimens showed a CD34-
expressing, dermal fibrocytic spindle-cell prolifer-
ation with extension into the subcutaneous fat, a
slight increase in interstitial mucin, and a subtle in-
crease in elongated elastic fibers with elastolysis.
The original definition of nephrogenic fibrosing
dermopathy included dermal fibroplasia with little
inflammation and mucin deposition, all of which
were observed in this case.
 
4
 
 Prominent elongated
elastic fibers, as seen in this case, have been de-
scribed in subsequent reports of nephrogenic fibros-
ing dermopathy.
 
5
 
 Multinucleated giant cells and
dystrophic calcification have also been reported.
The histologic differential diagnosis includes
other fibrotic cutaneous disorders (Table 3), pri-
marily scleromyxedema.
 
4,9,11-13
 
 Scleromyxedema is
generally characterized by a lymphoplasmacellular
infiltrate and prominent mucin deposition that can
aggregate into pools. Morphea differs from neph-
rogenic fibrosing dermopathy principally in the
lack of a spindle-cell proliferation. Lipodermato-
sclerosis classically displays so-called lipomem-
branous changes, characterized by microcysts lined
by eosinophilic, amorphous material forming
pseudopapillae. In the clinical context, the histo-
pathological features in this case best fit with neph-
rogenic fibrosing dermopathy.
 
Dr. Harris:
 
 Why were the findings of the first bi-
opsy considered to be more consistent with lipo-
dermatosclerosis?
 
Dr. Liu:
 
 There are some histologic similarities,
such as the superficial fibrosis that extends into
the deep panniculus, as well as some subtle stasis
changes that are characteristic of the lower leg,
though true lipomembranous change was absent.
Clinicopathological correlation is essential for the
diagnosis of this entity.
 
Dr. Harris:
 
 Dr. Kay, would you tell us how this pa-
tient was treated?
 
Dr. Kay:
 
 There is no effective treatment for neph-
rogenic fibrosing dermopathy. Physical therapy
should be initiated to maintain and attempt to im-
prove the range of motion of contracted joints. The
hands may be splinted in a functional position to
prevent progression of the contractures of the finger
joints. Various medical therapies have been ineffec-
tive, including topical steroids, selective H
 
2
 
-recep-
tor antagonists, cyclosporine, prednisone, immuno-
suppressive therapy, and photopheresis. Recently,
improvement was reported after plasmapheresis in
three patients. Thalidomide, an inhibitor of angio-
genesis
 
27
 
 and of tumor necrotic factor-
 
a
 
 produc-
tion,
 
28
 
 has been administered to several patients.
 
11
 
My colleagues and I have observed some softening
of skin in three patients treated with thalidomide.
However, other patients have not improved. We rec-
ommended physical therapy and thalidomide for
this patient.
 
Dr. Harris:
 
 Dr. Axelrod, as this patient’s physi-
cian, would you tell us about the subsequent man-
agement of his disease and the outcome?
 
Dr. Lloyd Axelrod 
 
(Medicine/Diabetes Unit): The
patient’s wishes were to walk and to go home. Un-
fortunately, neither was possible, and he spent the
last seven months of his life in a rehabilitation cen-
ter and in the hospital. As Dr. Kay suggested, we
treated his nephrogenic fibrosing dermopathy with
thalidomide and physical therapy. Both the patient
and his wife noted a gradual decrease in the firm-
ness of the skin of the lower extremities and an in-
crease in the range of motion of the knees, but this
was insufficient to enable him to walk. His last ad-
mission, two months before he died, was instructive
for physicians caring for patients with nephrogenic
fibrosing dermopathy. He had a persistent cough
and had newly diagnosed hypoxemia; evaluation
clinical diagnosis
dr.  samuel l.  moschella’s
diagnosis
pathological discussion
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revealed bilateral pleural effusions and ascites, al-
though his weight was unchanged and he did not
have pitting edema. We concluded that the nephro-
genic fibrosing dermopathy had led all of his physi-
cians to underestimate the degree of fluid overload;
the stiffness of his skin prevented the occurrence of
pitting edema of the lower extremities. Tissue loss
due to his enforced immobility, muscle wasting,
and reduced oral intake had offset the weight gain
that resulted from increased total body fluid. He un-
derwent dialysis and the excess fluid was removed,
with an ensuing reduction in weight of 17 kg. This
treatment resolved his cough and improved his
overall sense of well-being, his mental alertness,
and his vigor. The patient died six months after the
admission described.
 
A Physician:
 
 Is there any correlation between the
duration or severity of the renal disease and the de-
velopment of nephrogenic fibrosing dermopathy?
 
Dr. Kay:
 
 The occurrence of nephrogenic fibros-
ing dermopathy does not correlate directly with
the duration or severity of renal disease. Unlike
beta
 
2
 
-microglobulin amyloidosis, which typically
appears five to eight years after the initiation of
hemodialysis, nephrogenic fibrosing dermopathy
may develop after only a short period of hemodi-
alysis.
Nephrogenic fibrosing dermopathy.
anatomical diagnosis
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